Annovis Announces New Publication in a Peer-Reviewed Journal

MALVERN, Pa., May 21, 2024 -- Annovis Bio, Inc. , a clinical-stage drug platform company developing novel therapies for neurodegenerative diseases, announced the publication of a new article...

Related Keywords

Malvern ,Pennsylvania ,United States ,Posiphen Pharmacokinetics ,Annovis Bio ,Maria Maccecchini ,Annovis Bio Inc ,Securities Exchange ,Company Annual Report On Form ,Twitter ,Linkedin ,Special Issue ,Amyloid Protein ,Comparative Analysis ,Different Species ,Similar Absorption ,Securities Act ,Securities Exchange Act ,Annual Report ,Quarterly Reports ,